🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07833709
Starting soon Not applicable

Effectiveness of a Mindfulness-Based Cognitive Behavioral Mobile Intervention for Misophonia

NCT07833709 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-10-15
Last updated
2026-09-25

Condition(s) studied

MisophoniaMisophonia Treatment

Investigational drug(s) / intervention(s)

Mindfulness-Based Cognitive Behavioral Mobile Intervention

Mindfulness-Based Cognitive Behavioral Mobile Intervention: A three-week mobile behavioral intervention developed for adults with misophonia symptoms. The intervention integrates psychoeducation, cognitive behavioral techniques, self-monitoring, cognitive restructuring, graded exposure to trigger sounds, Subjective Units of Distress Scale (SUDS) monitoring, mindfulness practices, breathing exercises, relaxation techniques, and supportive audio content. The program is designed to target maladaptive thoughts, avoidance behaviors, emotional reactivity, physiological arousal, and difficulties in emotion regulation associated with misophonia.

Study summary

Misophonia is characterized by strong emotional and physiological reactions to specific trigger sounds and may interfere with daily functioning and emotional well-being. This randomized controlled trial will evaluate the effectiveness of a mobile application based on mindfulness-based cognitive behavioral interventions for adults with misophonia symptoms.

A total of 60 participants will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will use a three-week mobile intervention that includes psychoeducation, cognitive behavioral techniques, gradual exposure to trigger sounds, mindfulness, breathing and relaxation exercises, and self-monitoring tools. The control group will not receive the mobile intervention during the study period.

Outcomes will be assessed before the intervention, immediately after the three-week intervention, and four weeks after the intervention. The main outcome will be change in misophonia symptoms. Secondary outcomes will include depression, anxiety, stress, and difficulties in emotion regulation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older. * Meeting the misophonia criteria proposed by Jager et al. (2020). * Reporting at least one trigger sound. * Having a Misophonia Scale total score greater than 60.5. * Owning a smartphone or tablet. * Having sufficient technological literacy to use the mobile application. Exclusion Criteria: * Misophonia symptoms being better explained by another condition or disorder based on the eligibility screening. * A Misophonia Scale total score of 60.5 or lower. * Development of marked distress or functional impairment during the study that requires discontinuation and referral for professional mental health support.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sakarya University, Faculty of Health Sciences Sakarya Sakarya Üniversitesi

More Sakarya University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07833709 on ClinicalTrials.gov ↗ ← All trials in Turkey